We are thrilled to announce that Lydian assisted Eli Lilly in its investment in Augustine Therapeutics NV during their Series A financing round. Augustine Therapeutics, a Leuven-based biotech company, raised €17 million to advance its leading candidate treatment for neurological disorders.&
Our Commercial & Litigation team has updated the factsheet on evidence. The importance of providing (adequate) evidence in order to substantiate what a party is claiming must not be underestimated.
Over the past few years, the Belgian Data Protection Authority (the DPA) has emerged as a remarkably active regulator, both in its advisory and supervisory function. To provide an overview of its activities, the DPA recently published its Annual Report 2023 (the Annual Report). [1]
The Corporate Sustainability Due Diligence Directive (the CSDDD) will enter into force on 25 July 2024 following its publication in the Official Journal of the European Union on Friday 5 July 2024. As discussed in our previous contribution of 15 May 2024, the CSDDD essentially introduces ob
Our Commercial & Litigation team has updated the factsheet on the cost of legal proceedings. This memorandum gives a general overview of the costs of legal proceedings before the courts in Belgium. For any further questions on these topics, do not hesitate to contact any of our specialists
Statute of limitations is a defence that a debtor can raise against a creditor who has been idle for too long.
As summer is in full swing, many of us are planning our long-awaited vacations.
In our podcast's 12th episode, we delve into the topic of extra-contractual liability in the employment relationship with Kato Aerts, our podcast host and Employment Partner, and Liesbet Claessen, Associate in our Employment team.
Lydian is proud to have contributed to the European Journal of Compliance and Integrity, published by Anthemis! Bastiaan Bruyndonckx and Liese Kuyken, experienced lawyers within our Commercial & Litigation department, are authors of the article "Third-party management in the (re)insuran